Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Next-generation implantable defibrillator receives European approval

Boston Scientific : 09 October, 2007  (New Product)
Boston Scientific has received CE Mark approval for its Confient implantable cardioverter defibrillator (ICD) which is first Boston Scientific-branded cardiac rhythm management device to treat sudden cardiac death (SCD).
The Confient ICD is designed to reduce unnecessary right ventricular pacing and has an enhanced AV Search Hysteresis feature. The device also has a
wireless capability that is designed to save physicians time during the Implant procedure. The wireless capability allows device programming during wound closure and also eliminates the need for the wand in the sterile field. Time is also saved at follow-up with device interrogations that can be three times faster than the company's wanded telemetry.

'The Confient ICD is a tangible example of our Cardiac Rhythm Management group's ability to deliver meaningful product innovation,' said Jim Tobin, President and chief executive officer of Boston Scientific. 'We look forward to making this ICD broadly available to physicians so they can offer this advanced therapy to patients who are at risk of sudden cardiac death.'

Sudden cardiac death is the abrupt loss of heart function, usually due to an electrical rhythm dysfunction in the lower chambers of the heart, called ventricular fibrillation. Each year, sudden cardiac death claims the lives of as many as 350,000 people in Europe alone. More people die from sudden cardiac death each year than from lung cancer, breast cancer and AIDS combined.

The Confient ICD is not available for sale in the USA.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo